Kovler Diabetes Center celebrates 10 years, and looks ahead
Science Life talks to Kovler's director Louis Philipson, MD, PhD, about the center's unique contributions, and what's on the horizon for diabetes treatment. [Read more]
monogenic diabetes
The Business Case of Genetic Screening for Maturity Onset Diabetes of the Young
Rochelle Naylor finds that if you choose the right patients, genetic screening for maturity onset diabetes of the young can be cost-effective. [Read more]
Kovler Diabetes Center’s Monogenic Forum Focuses on Patients
The focus was on patients as researchers and families gathered for last week's Kovler Diabetes Center Monogenic Diabetes Family Forum. [Read more]
UChicago Experts Weigh in on Supreme Court Gene Patent Ruling
University of Chicago Medicine experts assess the impact of today's US Supreme Court decision that human genes cannot be patented. [Read more]
The Personalized Medicine Bargain
The future of medicine, we are told time and time again, is genetic and personalized. Someday, physicians will call up the genetic code of a patient and determine their genetic risks and which treatments will work most effectively with the fewest [Read more]
Transitioning from Mutation to Miracle
Diseases are rarely turned off like a light switch. As satisfying as it is to explain a biological mechanism at the genetic or cellular level, extrapolating those discoveries to a human level requires the mind to make difficult leaps of scale. [Read more]